2183.T
Price:
$294
Market Cap:
$6.64B
Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariat; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical m...[Read more]
Industry
Biotechnology
IPO Date
2008-10-27
Stock Exchange
JPX
Ticker
2183.T
According to Linical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -5.60. This represents a change of -69.98% compared to the average of -18.65 of the last 4 quarters.
The mean historical PE Ratio of Linical Co., Ltd. over the last ten years is 27.23. The current -5.60 PE Ratio has changed -2156.54% with respect to the historical average. Over the past ten years (40 quarters), 2183.T's PE Ratio was at its highest in in the June 2023 quarter at 1.31K. The PE Ratio was at its lowest in in the December 2024 quarter at -53.23.
Average
27.23
Median
29.48
Minimum
-13.41
Maximum
54.45
Discovering the peaks and valleys of Linical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 64.86%
Maximum Annual PE Ratio = 54.45
Minimum Annual Increase = -151.88%
Minimum Annual PE Ratio = -13.41
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -13.41 | -151.88% |
| 2024 | 25.84 | 64.86% |
| 2023 | 15.67 | -39.92% |
| 2022 | 26.09 | -20.65% |
| 2021 | 32.88 | -13.95% |
| 2020 | 38.21 | -29.83% |
| 2019 | 54.45 | 55.45% |
| 2018 | 35.02 | 51.61% |
| 2017 | 23.10 | -32.94% |
| 2016 | 34.45 | 33.50% |
The current PE Ratio of Linical Co., Ltd. (2183.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.37
5-year avg
17.41
10-year avg
27.23
Linical Co., Ltd.’s PE Ratio is greater than OncoTherapy Science, Inc. (-7.72), greater than K Pharma,Inc. (-8.48), less than ADR120S, Inc. (-4.03), less than Kohjin Bio Co., Ltd. (10.75), greater than Chiome Bioscience Inc. (-8.12), less than BrightPath Biotherapeutics Co., Ltd. (-4.87), greater than Noile-Immune Biotech Inc. (-7.81), greater than MEDINET Co., Ltd. (-5.63), greater than TMS Co., Ltd. (-8.89), less than StemCell Institute Inc. (38.49),
| Company | PE Ratio | Market cap |
|---|---|---|
| -7.72 | $6.77B | |
| -8.48 | $7.33B | |
| -4.03 | $7.41B | |
| 10.75 | $7.72B | |
| -8.12 | $7.35B | |
| -4.87 | $4.35B | |
| -7.81 | $6.11B | |
| -5.63 | $7.68B | |
| -8.89 | $5.96B | |
| 38.49 | $7.72B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Linical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Linical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Linical Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Linical Co., Ltd. (2183.T)?
What is the highest PE Ratio for Linical Co., Ltd. (2183.T)?
What is the 3-year average PE Ratio for Linical Co., Ltd. (2183.T)?
What is the 5-year average PE Ratio for Linical Co., Ltd. (2183.T)?
How does the current PE Ratio for Linical Co., Ltd. (2183.T) compare to its historical average?